Pharmacognosy intro
Zingiber officinale Roscoe, Zingiberaceae. Rhizome (fresh, dried, powdered) and steam-distilled essential oil. Listed in USP, European Pharmacopoeia, British Pharmacopoeia, Ayurvedic Pharmacopoeia of India, Japanese Pharmacopoeia, and Chinese Pharmacopoeia. Phytochemistry shifts between forms. Fresh ginger is dominated by 6-gingerol; upon drying, gingerols dehydrate to shogaols, with 6-shogaol two to three times more potent. Essential oil contains zingiberene (20-25%), beta-sesquiphellandrene, ar-curcumene, and citral (geranial, neral). The most established mechanism is 5-HT3 receptor antagonism. 6-Gingerol and 6-shogaol block the same receptor as ondansetron, directly explaining antiemetic activity. NK-1 receptor antagonism reinforces this by inhibiting substance P binding. The dual 5-HT3/NK-1 blockade mirrors modern combination antiemetic regimens. Muscarinic receptor antagonism contributes antispasmodic effects. Neuroprotective pathways are substantial. 6-Shogaol activates Nrf2/Keap1, inducing HO-1 and NQO1 in neuronal cells. 6-Gingerol suppresses NLRP3 inflammasome assembly. 6-Shogaol demonstrates HDAC inhibitory activity. Preclinical models show dopaminergic neuron protection and reduced alpha-synuclein aggregation. COX-1, COX-2, and 5-LOX are all inhibited. TRPV1 agonism drives thermogenesis. Saenghong et al. (2012, n=60, double-blind placebo-controlled) found 400-800 mg daily enhanced attention, working memory, and reaction time over two months. Ernst and Pittler's meta-analysis (2000) confirmed antiemetic efficacy with NNT of five to six for postoperative nausea. Bartels et al. (2015, 5 RCTs, n=593) confirmed moderate pain reduction in osteoarthritis. 6-Shogaol has improved blood-brain barrier permeability versus 6-gingerol, making dried preparations more relevant for cognitive applications. May potentiate anticoagulants and hypoglycemics. Contraindicated in active gallstone obstruction. Safe in pregnancy for nausea at up to one gram daily.